Zusammenfassung
Diese Arbeit bietet einen Überblick über Real-world-Ergebnisse bei glaukomchirurgischen Verfahren. Obwohl randomisierte klinische Studien wichtige Erkenntnisse liefern, spiegeln sie nicht das reale Versorgungsgeschehen wider. Real-world-Studien ermöglichen eine Beurteilung der Ergebnisse außerhalb kontrollierter Settings und sind für die Beratung und Entscheidungsfindung bei Glaukombehandlung von großer Bedeutung. Durch die Untersuchung von Real-world-Daten zielt die Arbeit darauf ab, seltene unerwünschte Ereignisse zu identifizieren, die in kontrollierten klinischen Studien möglicherweise übersehen werden. Der Fokus liegt darauf, die Wirksamkeit und Sicherheit von glaukomchirurgischen Verfahren über das kontrollierte Studiensetting hinaus zu bewerten.
Abstract
This article provides an overview of real-world outcomes in glaucoma surgical procedures. While randomized clinical trials provide valuable insights, they do not fully reflect real-world clinical practice. Real-world studies enable the evaluation of outcomes in uncontrolled settings and play a crucial role in counselling and decision-making for glaucoma treatment. By examining real-world data the article aims to identify rare adverse events that may go unnoticed in controlled clinical trials. The focus is on assessing the effectiveness and safety of glaucoma surgical procedures beyond the controlled trial setting.
Change history
26 January 2024
Zu diesem Beitrag wurde ein Erratum veröffentlicht: https://doi.org/10.1007/s00347-023-01973-8
Literatur
Holz FG, Tadayoni R, Beatty S, Berger A, Cereda MG, Cortez R et al (2015) Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration. Br J Ophthalmol 99:220–226
Wolfram C, Schuster AK (2022) Glaucoma care in Germany-results of a survey among German ophthalmologists-part 2: treatment. Ophthalmologie 119:1140–1148
Saheb H, Ahmed IIK (2012) Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol 23:96–104
Jordan JF, Wecker T, van Oterendorp C, Anton A, Reinhard T, Boehringer D et al (2013) Trabectome surgery for primary and secondary open angle glaucomas. Graefes Arch Clin Exp Ophthalmol 251:2753–2760
Akil H, Chopra V, Huang A, Loewen N, Noguchi J, Francis BA (2016) Clinical results of ab interno trabeculotomy using the Trabectome in patients with pigmentary glaucoma compared to primary open angle glaucoma. Clin Experiment Ophthalmol 44:563–569
Ting JLM, Damji KF, Stiles MC, Trabectome Study Group (2012) Ab interno trabeculectomy: outcomes in exfoliation versus primary open-angle glaucoma. J Cataract Refract Surg 38:315–323
Strzalkowska A, Strzalkowski P, Al Yousef Y, Grehn F, Hillenkamp J, Loewen NA (2021) Exact matching of trabectome-mediated ab interno trabeculectomy to conventional trabeculectomy with mitomycin C followed for 2 years. Graefes Arch Clin Exp Ophthalmol 259:963–970
Jea SY, Francis BA, Vakili G, Filippopoulos T, Rhee DJ (2012) Ab interno trabeculectomy versus trabeculectomy for open-angle glaucoma. Ophthalmology 119:36–42
Kornmann HL, Fellman RL, Feuer WJ, Butler MR, Godfrey DG, Smith OU et al (2019) Early results of goniotomy with the Kahook dual blade, a novel device for the treatment of glaucoma. Clin Ophthalmol 13:2369–2376
Sieck EG, Epstein RS, Kennedy JB, SooHoo JR, Pantcheva MB, Patnaik JL et al (2018) Outcomes of Kahook dual blade Goniotomy with and without phacoemulsification cataract extraction. Ophthalmol Glaucoma 1:75–81
Shue A, Levine RM, Gallousis GM, Teng CC (2019) Cyclodialysis cleft associated with Kahook dual blade goniotomy. J Curr Glaucoma Pract 13:74–76
Guedes RAP, Gravina DM, Lake JC, Guedes VMP, Chaoubah A (2019) Intermediate results of iStent or iStent inject implantation combined with cataract surgery in a real-world setting: a longitudinal retrospective study. Ophthalmol Ther 8:87–100
Klamann MKJ, Gonnermann J, Pahlitzsch M, Maier A‑KB, Joussen AM, Torun N et al (2015) iStent inject in phakic open angle glaucoma. Graefes Arch Clin Exp Ophthalmol 253:941–947
Bicket AK, Le JT, Azuara-Blanco A, Gazzard G, Wormald R, Bunce C et al (2021) Minimally invasive glaucoma surgical techniques for open-angle glaucoma: an overview of Cochrane systematic reviews and network meta-analysis. JAMA Ophthalmol 139:983–989
Grierson I, Saheb H, Kahook MY, Johnstone MA, Ahmed IIK, Schieber AT et al (2015) A novel Schlemm’s canal scaffold: histologic observations. J Glaucoma 24:460–468
Jabłońska J, Lewczuk K, Rękas MT (2023) Comparison of safety and efficacy of Hydrus and iStent combined with phacoemulsyfication in open angle glaucoma patients: 24-month follow-up. Int J Environ Res Public Health. https://doi.org/10.3390/ijerph20054152
Salimi A, Kassem R, Santhakumaran S, Harasymowycz P (2023) Three-year outcomes of a Schlemm canal microstent (Hydrus Microstent) with concomitant phacoemulsification in open-angle glaucoma. Ophthalmol Glaucoma 6:137–146
Pfeiffer N, Garcia-Feijoo J, Martinez-de-la-Casa JM, Larrosa JM, Fea A, Lemij H et al (2015) A randomized trial of a Schlemm’s canal microstent with phacoemulsification for reducing intraocular pressure in open-angle glaucoma. Ophthalmology 122:1283–1293
Loayza-Gamboa W, Martel-Ramirez V, Inga-Condezo V, Valderrama-Albino V, Alvarado-Villacorta R, Valera-Cornejo D (2020) Outcomes of combined prolene gonioscopy assisted transluminal trabeculotomy with phacoemulsification in open-angle glaucoma. Clin Ophthalmol 14:3009–3016
Cubuk MO, Ucgul AY, Unsal E (2020) Gonioscopy-assisted transluminal trabeculotomy as an option after failed trabeculectomy. Int Ophthalmol 40:1923–1930
Sharkawi E, Lindegger DJ, Artes PH, Lehmann-Clarke L, El Wardani M, Misteli M et al (2021) Outcomes of gonioscopy-assisted transluminal trabeculotomy in pseudoexfoliative glaucoma: 24-month follow-up. Br J Ophthalmol 105:977–982
Guo C‑Y, Qi X‑H, Qi J‑M (2020) Systematic review and Meta-analysis of treating open angle glaucoma with gonioscopy-assisted transluminal trabeculotomy. Int J Ophthalmol 13:317–324
Grover DS, Flynn WJ, Bashford KP, Lewis RA, Duh Y‑J, Nangia RS et al (2017) Performance and safety of a new ab interno gelatin stent in refractory glaucoma at 12 months. Am J Ophthalmol 183:25–36
Reitsamer H, Sng C, Vera V, Lenzhofer M, Barton K, Stalmans I et al (2019) Two-year results of a multicenter study of the ab interno gelatin implant in medically uncontrolled primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 257:983–996
Mansouri K, Bravetti GE, Gillmann K, Rao HL, Ch’ng TW, Mermoud A (2019) Two-year outcomes of XEN gel Stent surgery in patients with open-angle glaucoma. Ophthalmol Glaucoma 2:309–318
Gillmann K, Bravetti GE, Rao HL, Mermoud A, Mansouri K (2021) Combined and stand-alone XEN 45 gel stent implantation: 3‑year outcomes and success predictors. Acta Ophthalmol 99:e531–e539
Lenzhofer M, Kersten-Gomez I, Sheybani A, Gulamhusein H, Strohmaier C, Hohensinn M et al (2019) Four-year results of a minimally invasive transscleral glaucoma gel stent implantation in a prospective multi-centre study. Clinical Exper Ophthalmology. https://doi.org/10.1111/ceo.13463
Rauchegger T, Angermann R, Willeit P, Schmid E, Teuchner B (2021) Two-year outcomes of minimally invasive XEN Gel Stent implantation in primary open-angle and pseudoexfoliation glaucoma. Acta Ophthalmol 99:369–375
Sng CC, Wang J, Hau S, Htoon HM, Barton K (2018) XEN-45 collagen implant for the treatment of uveitic glaucoma. Clin Experiment Ophthalmol 46:339–345
Bormann C, Schmidt M, Busch C, Rehak M, Scharenberg CT, Unterlauft JD (2022) Implantation of XEN after failed trabeculectomy: an efficient therapy? Klin Monbl Augenheilkd 239:86–93
Buffault J, Graber M, Bensmail D, Bluwol É, Jeanteur M‑N, Abitbol O et al (2020) Efficacy and safety at 6 months of the XEN implant for the management of open angle glaucoma. Sci Rep 10:4527
Gupta C, Mathews D (2019) XEN® stent complications: a case series. BMC Ophthalmol 19:253
Karri B, Gupta C, Mathews D (2018) Endophthalmitis following XEN stent exposure. J Glaucoma 27:931–933
Theilig T, Rehak M, Busch C, Bormann C, Schargus M, Unterlauft JD (2020) Comparing the efficacy of trabeculectomy and XEN gel microstent implantation for the treatment of primary open-angle glaucoma: a retrospective monocentric comparative cohort study. Sci Rep 10:19337
Cappelli F, Cutolo CA, Olivari S, Testa V, Sindaco D, Pizzorno C et al (2022) Trabeculectomy versus Xen gel implant for the treatment of open-angle glaucoma: a 3-year retrospective analysis. BMJ Open Ophthalmol 7:e830
Baker ND, Barnebey HS, Moster MR, Stiles MC, Vold SD, Khatana AK et al (2021) Ab-externo microshunt versus trabeculectomy in primary open-angle glaucoma: one-year results from a 2-year randomized, multicenter study. Ophthalmology 128:1710–1721
Pawiroredjo SSM, Bramer WM, Pawiroredjo ND, Pals J, Poelman HJ, de Vries VA et al (2022) Efficacy of the PRESERFLO microshunt and a meta-analysis of the literature. J Clin Med Res. https://doi.org/10.3390/jcm11237149
Fea AM, Laffi GL, Martini E, Economou MA, Caselgrandi P, Sacchi M et al (2022) Effectiveness of microshunt in patients with primary open-angle and pseudoexfoliative glaucoma: a retrospective European multicenter study. Ophthalmol Glaucoma 5:210–218
Quaranta L, Micheletti E, Carassa R, Bruttini C, Fausto R, Katsanos A et al (2021) Efficacy and safety of PreserFlo® microshunt after a failed trabeculectomy in eyes with primary open-angle glaucoma: a retrospective study. Adv Ther 38:4403–4412
Micheletti E, Riva I, Bruttini C, Quaranta L (2020) A case of delayed-onset hemorrhagic choroidal detachment after PreserFlo Microshunt implantation in a glaucoma patient under anticoagulant therapy. J Glaucoma 29:e87–e90
Brambati M, Bettin P, Ramoni A, Battista M, Bandello F (2022) A case of endophthalmitis following needling procedure after PRESERFLO® Micro Shunt implantation. Eur J Ophthalmol 32:NP83–NP86
Jamke M, Herber R, Haase MA, Jasper CS (2023) PRESERFLOTM MicroShunt versus trabeculectomy: 1‑year results on efficacy and safety. Graefes Arch Clin Exp Ophthalmol. https://doi.org/10.1007/s00417-023-06075-4
Wagner FM, Schuster AK, Munder A, Muehl M, Chronopoulos P, Pfeiffer N et al (2022) Comparison of subconjunctival microinvasive glaucoma surgery and trabeculectomy. Acta Ophthalmol 100:e1120–e1126
Kuet M‑L, Azuara-Blanco A, Barton K, King AJ (2022) Will the PRESERFLOTM MicroShunt impact the future of trabeculectomy practice? A UK and Éire Glaucoma Society National Survey. Eye. https://doi.org/10.1038/s41433-022-02326-6
Stingl JV, Wagner FM, Liebezeit S, Baumgartner R, Spät H, Schuster AK et al (2023) Long-term efficacy and safety of modified canaloplasty versus trabeculectomy in open-angle glaucoma. Life. https://doi.org/10.3390/life13020516
Nassri L, Plange N, Lindemann F, Schellhase H, Walter P, Kuerten D (2020) Therapieerfolg von Kanaloplastik und Trabekulektomie durch denselben Operateur mit demselben Erfahrungslevel im Langzeitverlauf. Ophthalmologe 117:1025–1032
Grieshaber MC, Pienaar A, Olivier J, Stegmann R (2010) Canaloplasty for primary open-angle glaucoma: long-term outcome. Br J Ophthalmol 94:1478–1482
Seuthe A‑M, Ivanescu C, Leers S, Boden K, Januschowski K, Szurman P (2016) Modified canaloplasty with suprachoroidal drainage versus conventional canaloplasty-1-year results. Arbeitsphysiologie 254:1591–1597
Gesser C, Wiermann A, Keserü M, Richard G, Klemm M (2014) Long-term follow-up after deep sclerectomy. Klin Monbl Augenheilkd 231:535–539
Shaarawy T, Mansouri K, Schnyder C, Ravinet E, Achache F, Mermoud A (2004) Long-term results of deep sclerectomy with collagen implant. J Cataract Refract Surg 30:1225–1231
Schuster AK, Uhrig M, Pfeiffer N, Hoffmann EM (2022) Wie lernt man eine Trabekulektomie operieren? Die Ophthalmol 119:1006–1016
Landers J, Martin K, Sarkies N, Bourne R, Watson P (2012) A twenty-year follow-up study of trabeculectomy: risk factors and outcomes. Ophthalmology 119:694–702
Wagner FM, Schuster AK, Kianusch K, Stingl J, Pfeiffer N, Hoffmann EM (2023) Long-term success after trabeculectomy in open-angle glaucoma: results of a retrospective cohort study. BMJ Open 13:e68403
Chen PP (2003) Blindness in patients with treated open-angle glaucoma. Ophthalmology 110:726–733
Singh J, O’Brien C, Chawla HB (1995) Success rate and complications of intraoperative 0.2 mg/ml mitomycin C in trabeculectomy surgery. Eye 9(Pt 4):460–466
Edmunds B, Thompson JR, Salmon JF, Wormald RP (2002) The National Survey of Trabeculectomy. III. Early and late complications. Eye 16:297–303
Feiner L, Piltz-Seymour JR (2003) Collaborative Initial Glaucoma Treatment Study: a summary of results to date. Curr Opin Ophthalmol 14:106–111
Montesano G, Ometto G, King A, Garway-Heath DF, Crabb DP (2023) Two-year visual field outcomes of the treatment of advanced glaucoma study (TAGS). Am J Ophthalmol 246:42–50
Weber C, Hundertmark S, Brinken R, Holz FG, Mercieca K (2022) Erste klinische Ergebnisse mit dem PAUL®-Glaukom-Implantat an der Universitäts-Augenklinik Bonn. Ophthalmologie 119:1267–1274
Goulet RJ 3rd, A‑DT P, Cantor LB, WuDunn D (2008) Efficacy of the Ahmed S2 glaucoma valve compared with the Baerveldt 250-mm2 glaucoma implant. Ophthalmology 115:1141–1147
Gedde SJ, Schiffman JC, Feuer WJ, Herndon LW, Brandt JD, Budenz DL (2009) Three-year-follow-up of the tube versus Trabeculectomy study. Am J Ophthalmol 148(5):670–684
Godinho G, Barbosa-Breda J, Oliveira-Ferreira C, Madeira C, Melo A, Falcão-Reis F et al (2021) Anterior chamber versus ciliary Sulcus Ahmed glaucoma valve tube placement: longitudinal evaluation of corneal endothelial cell profiles. J Glaucoma 30:170–174
Iwasaki K, Arimura S, Takihara Y, Takamura Y, Inatani M (2018) Prospective cohort study of corneal endothelial cell loss after Baerveldt glaucoma implantation. PLoS ONE 13:e201342
José P, Barão RC, Teixeira FJ, Marques RE, Peschiera R, Barata A et al (2022) One-year efficacy and safety of the PAUL glaucoma implant using a standardized surgical protocol. J Glaucoma 31:201–205
Tan MCJ, Choy HYC, Koh Teck CV, Aquino MC, Sng CCA, Lim DKA et al (2022) Two-year outcomes of the Paul glaucoma implant for treatment of glaucoma. J Glaucoma 31:449–455
Wang S, Gao X, Qian N (2016) The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma: a meta-analysis. BMC Ophthalmol 16:83
Hoffmann EM, Hengerer F, Klabe K, Schargus M, Thieme H, Voykov B (2021) Glaucoma surgery today. Ophthalmologe 118:239–247
Samuelson TW, Sarkisian SR Jr, Lubeck DM, Stiles MC, Duh Y‑J, Romo EA et al (2019) Prospective, randomized, controlled pivotal trial of an Ab Interno implanted trabecular micro-bypass in primary open-angle glaucoma and cataract: two-year results. Ophthalmology 126:811–821
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
A. Strzalkowska, E.M. Hoffmann, P. Strzalkowski, J.V. Stingl, N. Pfeiffer und K. Schuster geben an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autor/-innen keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
Hinweis des Verlags
Der Verlag bleibt in Hinblick auf geografische Zuordnungen und Gebietsbezeichnungen in veröffentlichten Karten und Institutsadressen neutral.
QR-Code scannen & Beitrag online lesen
Die Originalversion dieses Beitrags wurde korrigiert: der Name von dem Autor Alexander K. Schuster fälschlicherweise als „K. Schuster“ angegeben. Außerdem wurden die Vornamen von den anderen Autor*innen nun ausgeschrieben: Alicja Strzalkowska, Esther M. Hoffmann, Piotr Strzalkowski, Julia V. Stingl und Norbert Pfeiffer.
Rights and permissions
About this article
Cite this article
Strzalkowska, A., Hoffmann, E.M., Strzalkowski, P. et al. Real-world-Ergebnisse von glaukomchirurgischen Verfahren beim Offenwinkelglaukom. Ophthalmologie 120, 1107–1116 (2023). https://doi.org/10.1007/s00347-023-01941-2
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00347-023-01941-2